US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Russia Pharmaceuticals and Healthcare Report Q1 2015
12/24/2014 | published by: Business Monitor International
... Russia's ageing population andsignificant disease burden will act to underpin pharmaceutical expenditure growth over the long term. Headline Expenditure Projections Pharmaceuticals: RUB786.50bn (USD24.68bn) in 2013 to RUB857.79bn (USD23.79bn) in 2014;+9.1% in local currency terms and ...  |  read more...
USD 1,295
Morocco Pharmaceuticals and Healthcare Report Q1 2015
12/31/2014 | published by: Business Monitor International
... phase ofits universal health insurance scheme will drive an increase in pharmaceutical spending. The country'sreliance on pharmaceutical imports will provide opportunities for multinational drugmakers, though theinefficient regulatory environment is a risk to operating in Morocco. ...  |  read more...
USD 1,295
Qatar Pharmaceuticals and Healthcare Report Q1 2015
12/31/2014 | published by: Business Monitor International
... to invest in healthcareinfrastructure. Meanwhile, the Qatari government has decided to make health insurance compulsory fornon-nationals. The new law will ensure more competitive pricing of services among healthcare providers inthe country, as it will enable ...  |  read more...
USD 1,295
Global Natamycin Industry 2014 Market Research Report
12/30/2014 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Natamycin basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Bangladesh Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... non-communicablediseases, this represents an epidemiological transition that will present new opportunities forpharmaceutical companies. Headline Expenditure Projections Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.62bn (USD1.99bn) in 2014; +11.4%in local currency terms and +11.9% in US dollar ...  |  read more...
USD 1,295
India Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... reform willhelp unlock the potential of the large Indian market. Headline Expenditure Projections Pharmaceuticals: INR904.0bn (USD15.4bn) in 2013 to INR1,021.8bn (USD17.0bn) in 2014; +13.0% inlocal currency terms and +10.36% in US dollar terms. Healthcare: INR4,640bn ...  |  read more...
USD 1,295
Finland Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... for the treatmentof long-term illnesses, drug manufacturers will be pressured to reduce drug prices as the governmentincreases its cost-containment measures. Political uncertainty along with the country's weak economicoutlook adds further downward pressure to our forecast. ...  |  read more...
USD 1,295
Philippines Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... for an increasingshare of pharmaceutical sales in the Philippines, galvanised by expanding government provision ofhealthcare as well as improvements in generic drug distribution. This provides strong growth opportunitiesfor generic drug manufacturers in an emerging market ...  |  read more...
USD 1,295
Global Zonisamide Industry 2014 Market Research Report
12/22/2014 | published by: 9Dimen Research
... including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Zonisamide basic information including Zonisamide definition, classification, application and industry chain overview; ...  |  read more...
USD 2,850
Zimbabwe Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... to reduce the proportion ofcounterfeit medicines in circulation and increase the country's attractiveness to multinational drugmakers.Nevertheless, for the foreseeable future the dire economic and political outlook, reduced healthcare budgetand underdeveloped local manufacturing industry will continue ...  |  read more...
USD 1,295
Global Valsartan Industry 2014 Market Research Report
12/22/2014 | published by: 9Dimen Research
... including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Valsartan basic information including Valsartan definition, classification, application and industry chain overview; ...  |  read more...
USD 2,850
Belgium Pharmaceuticals and Healthcare Report Q1 2015
12/24/2014 | published by: Business Monitor International
... strategic regional hubfor multinational drugmakers. Notwithstanding a particularly sluggish recovery from the eurozone crisis,per capita pharmaceutical expenditure remains markedly above the regional average and widespreadaccess to healthcare will continue to support already high demand for ...  |  read more...
USD 1,295
Oman Pharmaceuticals and Healthcare Report Q1 2015
12/31/2014 | published by: Business Monitor International
... this investment isallocated to building state-of-the-art healthcare infrastructure in an attempt to promote the medical tourismindustry. We highlight continuing commercial opportunities in the Omani pharmaceutical market formultinational drugmakers due to the high penetration of patented ...  |  read more...
USD 1,295
Ireland Pharmaceuticals and Healthcare Report Q1 2015
12/24/2014 | published by: Business Monitor International
... industry that allow companies to beheadquartered in Ireland. This is reflected in the recent withdrawal of various M&A deals, including thetermination of the merger between AbbVie and Shire, for which transaction terms were already undernegotiation ...  |  read more...
USD 1,295
Malaysia Pharmaceuticals and Healthcare Report Q1 2015
12/24/2014 | published by: Business Monitor International
... of theGoods and Service Tax on medicine prices will provide companies with significant revenue-earningopportunities. However, downside risks to our outlook include further economic slowdown forecast for2015, worries of an increasing number of imitation drugs and ...  |  read more...
USD 1,295
Peru Pharmaceuticals and Healthcare Report Q1 2015
12/24/2014 | published by: Business Monitor International
... and benefitingfrom pharmaceutical investments. Steady increases in the growth of the Peruvian pharmaceutical marketand a commitment to healthcare improvements will generate revenue opportunities for multinationalinvestors. Headline Expenditure Projections Pharmaceuticals: PEN4.38bn (USD1.62bn) in 2013 to PEN4.66bn ...  |  read more...
USD 1,295
Indonesia Pharmaceuticals and Healthcare Report Q1 2015
12/31/2014 | published by: Business Monitor International
... theASEAN Economic Community. However, this potential is weighed on by the newly passed law requiringhalal certification, which is expected to be enforced by 2019. Headline Expenditure Projections Pharmaceuticals: IDR63,806bn (USD6.11bn) in 2013 to IDR69,493bn (USD5.86bn) ...  |  read more...
USD 1,295
Spain Pharmaceuticals and Healthcare Report Q1 2015
12/31/2014 | published by: Business Monitor International
... hinderthe country's attractiveness to drugmakers. Despite calls made by companies for the implementation of asystem that adequately rewards innovation and supports investment in future medicines, the government islikely to remain committed to fiscal consolidation and ...  |  read more...
USD 1,295
Bahrain Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... toseveral preventive health projects planned. Despite recent price cuts negatively impacting the market in theshort term, we believe an ageing population, increasing chronic disease burden and robust economicgrowth will drive medicine demand for many years ...  |  read more...
USD 1,295
Belarus Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... Furthermore, wage growthmandated by the government will become unsustainable, threatening to dampen internal consumption. Belarus will present little reward for high risk for most pharmaceutical companies in the region. Headline Expenditure Projections Pharmaceuticals: BYR8,927bn in ...  |  read more...
USD 1,295
China Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... drugmanufacturers despite the downside risks of pharmaeconomics and the government's crackdown on illegalpractices. Headline Expenditure Projections Pharmaceuticals: CNY532.4bn (USD86.6bn) in 2013 to CNY616.1bn (USD100.6bn) in 2014; +15.7%in local currency and +16.1% in US dollar terms. ...  |  read more...
USD 1,295
Kazakhstan Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... term, the introduction ofcompulsory health insurance will create a large pool of funding for further growth. However, a key risk toour outlook is oil prices and their effect on Kazakh government revenues. Headline Expenditure Projections ...  |  read more...
USD 1,295
United Kingdom Pharmaceuticals and Healthcare Report Q1 2015
12/17/2014 | published by: Business Monitor International
... for over 80% of total healthcarespending. With a higher prevalence of non-communicable diseases, coupled with an ageing population, theincreased demand for healthcare may lead to the enforcement of cost-containment strategies and movementaway from expensive treatment ...  |  read more...
USD 1,295
Global Vilazodone hydrochloride Industry 2014 Market Research Report
12/22/2014 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Vilazodone hydrochloride basic information including Vilazodone hydrochloride definition, classification, ...  |  read more...
USD 2,850
Pharmaceuticals Markets in China
1/1/2015 | published by: Asia Market Information & Development Company
... a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ...  |  read more...
USD 4,000
  2    4  5  6  7  8  9  10